ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA

Clinical trials for ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA trials appear

Sign up with your email to follow new studies for ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New oral drug trial offers hope for rare, Hard-to-Treat adrenal tumors

Disease control Recruiting now

This study is testing an experimental oral medication called ONC206 for people with advanced pheochromocytoma or paraganglioma, rare tumors that often don't respond to standard treatments. About 90 participants will take the drug in different doses to see if it shrinks tumors and…

Matched conditions: ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA

Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA

Get alerted when new ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA trials appear

New oral drug trial offers hope for rare, Hard-to-Treat adrenal tumors